Abstract: A method of manufacturing a hypoid gear includes face hobbing a gear blank and forming a green hypoid gear with gear teeth, heat treating the green hypoid gear to form a heat treated hypoid gear with heat treated gear teeth, and hard hobbing the heat treated gear teeth to form a hard finished hypoid gear. Critical non-tooth features on the heat treated hypoid gear are hard finished. Also, the critical non-tooth features on the heat treated hypoid gear can be hard finished prior to hard hobbing the heat treated gear teeth. The heat treating includes at least one of carburizing and induction hardening the green hypoid gear, a surface of the heat treated gear teeth has a hardness greater than or equal to 58 HRC, and the hard hobbing removes heat distortion from the heat treated gear teeth.

Abstract: A method of manufacturing a hypoid gear includes face hobbing a gear blank and forming a green hypoid gear with gear teeth, heat treating the green hypoid gear to form a heat treated hypoid gear with heat treated gear teeth, and hard hobbing the heat treated gear teeth to form a hard finished hypoid gear. Critical non-tooth features on the heat treated hypoid gear are hard finished. Also, the critical non-tooth features on the heat treated hypoid gear can be hard finished prior to hard hobbing the heat treated gear teeth. The heat treating includes at least one of carburizing and induction hardening the green hypoid gear, a surface of the heat treated gear teeth has a hardness greater than or equal to 58 HRC, and the hard hobbing removes heat distortion from the heat treated gear teeth.

Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.

Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.

Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.

Abstract: The invention provides methods of making designed and constructed protein (e.g., antibody) libraries and libraries resulting from the same.

Abstract: The present invention provides novel high-valent palladium fluoride complexes. The complexes typically include multi-dentate ligands that stabilize the octahedral coordination sphere of the palladium(IV) atom. These complexes are useful in fluorinating organic compounds, in particular aryl-containing compounds. The invention is particularly useful for fluorinating compounds with 19F for PET imaging.

Abstract: The invention provides methods of making designed and constructed protein (e.g., antibody) libraries and libraries resulting from the same.

Abstract: The invention provides methods of making designed and constructed protein (e.g., antibody) libraries and libraries resulting from the same.

Abstract: The invention provides methods of making designed and constructed protein (e.g., antibody) libraries and libraries resulting from the same.

Abstract: A thermal manager has a digital filter whose input is to receive raw temperature values from a sensor and whose output is to provide processed or filtered temperature values according to a filter function that correlates temperature at the sensor with temperature at another location in the device. The thermal manager has a look-up table that further correlates temperature at the sensor with temperature at the other location. The look-up table contains a list of processed temperature sensor values, and/or a list of temperatures representing the temperature at the other location, and their respective power consumption change commands. The thermal manager accesses the look-up table using selected, filtered temperature values, to identify their respective power consumption change commands. The latter are then evaluated and may be applied, to mitigate a thermal at the other location. Other embodiments are also described and claimed.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: A suture passer device includes a shaft, a handle, an end effector, and a suture capturing member. The shaft has a shaft proximal end and a shaft distal end. The handle assembly is coupled to the shaft proximal end. The end effector is coupled to the shaft distal end. The suture capturing member is within the end effector, is coupled to the handle assembly independently of the shaft, and is configured to capture a suture within the end effector.

Abstract: The invention relates to the identification and generation of antibodies that bind to TMEFF2 proteins which are involved in cancer. Further, the invention provides for the use of these antibodies in the treatment of cancer.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: The present invention provides novel high-valent palladium fluoride complexes. The complexes typically include multi-dentate ligands that stabilize the octahedral coordination sphere of the palladium(IV) atom. These complexes are useful in fluorinating organic compounds, in particular aryl-containing compounds. The invention is particularly useful for fluorinating compounds with 19F for PET imaging.

Abstract: A suture passer device includes a shaft, a handle, an end effector, and a suture capturing member. The shaft has a shaft proximal end and a shaft distal end. The handle assembly is coupled to the shaft proximal end. The end effector is coupled to the shaft distal end. The suture capturing member is within the end effector, is coupled to the handle assembly independently of the shaft, and is configured to capture a suture within the end effector.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.